SYD-101 contains a low dose of atropine sulfate, an antimuscarinic agent, in an ophthalmic solution. The NDA is supported by data from the phase 3 STAR trial (ClinicalTrials.gov Identifier: ...
The United Nations’ top official for the Middle East warned Tuesday that the window may be closing on the possibility of achieving a two-state solution for Israelis and Palestinians.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback